- Home
- NVO vs ADI Comparison
NVO vs ADI Comparison
Compare NVO & ADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | ADI |
|---|---|---|
| Founded | 1923 | 1965 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.2B | 179.0B |
| IPO Year | 2001 | 1994 |
Fundamental Metrics
Financial Performance| Metric | NVO | ADI |
|---|---|---|
| Price | $46.73 | $381.23 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 22 |
| Target Price | $51.00 | ★ $385.45 |
| AVG Volume (30 Days) | ★ 11.3M | 3.7M |
| Earning Date | 05-06-2026 | 05-20-2026 |
| Dividend Yield | ★ 3.19% | 1.13% |
| EPS Growth | N/A | ★ 39.02 |
| EPS | N/A | ★ 4.09 |
| Revenue | N/A | ★ $6,200,942,000.00 |
| Revenue This Year | N/A | $28.41 |
| Revenue Next Year | $3.70 | $10.25 |
| P/E Ratio | ★ $13.60 | $93.81 |
| Revenue Growth | N/A | ★ 21.41 |
| 52 Week Low | $35.12 | $223.47 |
| 52 Week High | $64.16 | $449.52 |
Technical Indicators
Market Signals| Indicator | NVO | ADI |
|---|---|---|
| Relative Strength Index (RSI) | 45.43 | 49.70 |
| Support Level | $45.62 | $375.59 |
| Resistance Level | $46.92 | $404.53 |
| Average True Range (ATR) | 1.36 | 11.29 |
| MACD | -0.28 | 2.48 |
| Stochastic Oscillator | 34.08 | 65.79 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About ADI Analog Devices Inc.
Analog Devices is a leading analog, mixed-signal, and digital-signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers; more than half of its chip sales are to industrial and automotive end markets. ADI's chips are also incorporated into wireless infrastructure equipment.